72 237

Cited 19 times in

Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression.

Authors
Kang, SU; Lee, BS; Lee, SH; Baek, SJ; Shin, YS; Kim, CH
Citation
The Journal of nutritional biochemistry, 24(6):986-999, 2013
Journal Title
The Journal of nutritional biochemistry
ISSN
0955-28631873-4847
Abstract
Epigallocatechin-3-gallate (EGCG), a major polyphenolic constituent of green tea, possesses remarkable chemopreventive and therapeutic potential against various types of cancer, including head and neck squamous cell carcinoma (HNSCC). However, the molecular mechanism involved is not completely understood. Nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1), a transforming growth factor β superfamily protein, is shown to be induced by several antitumorigenic compounds and to exhibit proapoptotic and antitumorigenic activities. In this report, we demonstrate that EGCG transcriptionally induced the expression of NAG-1 during EGCG-induced apoptosis of HNSCC cells. Reporter assays, using the luciferase constructs containing the NAG-1 promoter, demonstrate that p53 is required for EGCG-mediated activation of NAG-1. Overexpression of NAG-1 enhanced the apoptotic effect of EGCG, whereas suppression of NAG-1 expression by small interfering RNA attenuated EGCG-induced apoptosis in HNSCC cells. Subsequently, we found that ataxia-telangiectasia mutated (ATM) plays an important role in activating these proapoptotic proteins (NAG-1 and p53) and cell cycle inhibitor (p21). Furthermore, EGCG significantly inhibited tumor formation as assessed by xenograft models, and this result is accompanied with induction of apoptotic cells and NAG-1 expression in tumor tissue samples. Taken together, these results demonstrate for the first time that EGCG induces apoptosis via ATM/p53-dependent NAG-1 expression in HNSCC, providing an additional mechanistic explanation for the apoptotic activity of EGCG.
MeSH terms
Anticarcinogenic Agents/*pharmacologyApoptosisAtaxia Telangiectasia Mutated Proteins/*genetics/metabolismCarcinoma, Squamous Cell/drug therapy/*genetics/metabolismCatechin/*analogs & derivatives/pharmacologyCell Line, TumorGrowth Differentiation Factor 15/*geneticsHead and Neck Neoplasms/drug therapy/*genetics/metabolismHeterograftsHumansRNA, Small Interfering/metabolismTumor Suppressor Protein p53/*genetics/metabolism
DOI
10.1016/j.jnutbio.2012.07.003
PMID
23017582
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Otolaryngology
AJOU Authors
강, 성운이, 복순신, 유섭김, 철호
Full Text Link
Files in This Item:
fulltext not available.txtDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse